0 followers
With access to a reservoir of unexploited intracellular cancer targets, CDR-Life is advancing a growing pipeline of highly tumor-selective immunotherapies.
Christian Leisner
Lonza
37 followers
Roche
283 followers
Synthekine
3 followers
Caribou Biosciences
2 followers
Vera Therapeutics
2 followers
Neogene Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Day One Biopharmaceuticals
1 follower
Isotopen Technologien München
1 follower
Aura Biosciences
1 follower
CG Oncology
1 follower
Explore companies